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Abstract:
Background:
A large number of classical and recently discovered plants are indicated in preventing and/or treating Alzheimer’s disease (AD).
Objective:
Name of plants with their anti-AD effects are important for their further use and investigation.
Method:
A short overview of AD is given; anti-Alzheimer plants are given in a Table.
Results:
Various medicinal plants are listed here as sources of popular medicines to be used in cases when patients are afraid of developing
and/or suffer from AD. Some of these plants have been used for centuries. The major sources in the literature, over one hundred of
references are given for plants that show beneficial effect on the progress of AD.
Conclusion:
Plant extracts are widely used addition to the synthetic drugs approved by various administrative authorities to stop/slow down the
progress of symptoms of AD.
Keywords: Alzheimer’s disease, Anti-AD effect, Etiopathogenesis, Amyloid fibers, Medicinal plants, Galantamine.
1. INTRODUCTION
Currently, Alzheimer’s disease (AD) is one of the leading, neuro-degenerative diseases most commonly affecting
people over 65 [1]. Its  etiopathogenesis  is still  shrouded in  mystery. Since  the description  of AD,  several landmark
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discoveries pertaining to the pathogenesis of AD have been postulated. The major findings include  the definition  of
hallmark events  such as formation  and accumulation  of amyloid fibers,  and over the  years, it has become evident that
defective protein processing is involved in AD [2]. The earlier notion was that the onset of AD could present itself years
before the establishment of diagnosis, while unambiguous pathological events  such  as  protein  misfolding/aggregation
could  occur  at  later  stages  of  the  progress  of  the  disease.  However,  after  several  landmark  studies,  numerous
pathomechanisms have been postulated concerning the development of AD, besides the identification its biomarkers
[3]. It is now evident that vascular and metabolic syndromes/dysfunctions, could also play part in AD. In particular,
inflammation, oxidative stress and endothelial dysfunction are now believed to promote the development of AD. The
involvement of metabolic perturbations in the development of AD was braced by clinical epidemiological studies [4]
and  was  proved  to  associate  with  diseases  such  as  diabetes  mellitus,  dyslipidemia,  hypertension,  obesity,  wherein
oxidative stress and insulin resistance were enhanced [5]. Given the complex interplay of cellular signaling and nexus
with  metabolic  diseases,  several  efforts  have  been  directed  to  the  identification  of  therapeutic  targets/approach  to
combat AD. Genetic, pharmacological and cell biological studies continue to unravel the possibility of targeting the
effector molecules, pathways of inflammation and oxidative stress. Plants have been confirmed to be essential agents in
maintaining general well-being for everyone and their importance in the human diet has been unquestioned in modern
science  [6].  Furthermore,  medicinal  plants  provide  a  myriad  of  biologically  active  molecules  and  these  have  been
utilized  in  medicine  for  thousands  of  years.  The  utilization  of  these  special  plants  and  herbs  marked  the  dawn  of
discovery in the area of pharmacologically active ligands [7]. Neurodegenerative disorders like AD itself are currently a
therapeutic enigma with huge socioeconomic impact on improved life expectancy due to advancement in health care.
Although the pathological and clinical aspects of these incapacitating disorders are explored to a certain extent, still the
treatments applied these days provide only symptomatic relief with no improvement concerning the course or delay in
the progression of the disease in question.
An increasing number of herbal extracts, poly-herbal and herbo-mineral preparations and phytochemicals obtained
from herbs have been studied for their neuroprotective potential in AD for the past decade. These above mentioned
studies have supplied us with utilizable new drug therapies based on medicinal plants.
2. METHODS
This review gives an overview of beneficial in vitro and in vivo adaptation of various plant extracts in AD. The
therapeutic  potential  and  postulated  ways  of  action  of  these  agents  have  been  thoroughly  examined  in  multiple
experiments in earlier reviews [8, 9]. Recent reviews have focused on the therapeutic potential of traditional medicinal
plants  and  their  active  components  obtained  from  Chinese  herbs  for  AD  and  cognitive  impairment  [10].  As
neurofibrillary tangles and amyloid plaques are characterized by deficiency in cholinergic transmission in the basal
forebrain, the inhibitors of the enzyme involved in the synthesis of acetylcholine (ACh). The first clinically approved
and available AChE inhibitor was tacrine, however, from 2013 onwards it was discontinued in the USA. Nowadays,
donepezil and rivastigmine are used in the treatment of AD. Recently, galantamine, an alkaloid obtained from plants of
the Amaryllis family, has been developed. Currently, there are still ongoing clinical trials for galantamine. However,
approved by the FDA, it is already used for the treatment of mild to moderate AD.
Encouraged by the success of galantamine, several medicinal plants and phytochemicals have been evaluated for the
inhibitory effect against acetylcholine esterase enzyme (AChE) in both in vitro and in vivo models of AD.
A variety of plants reported to show inhibition of AChE, may be considered promising for the treatment of AD
associated cognitive decline [11]. Given the clustering of multiple factors involved in the pathogenesis of AD, new
therapeutic targets have been selected to develop novel drugs and manage the multiple complications occurring along
with AD.
Traditional  medicines  are  being  rediscovered  for  the  fulfilment  of  a  strategy  aimed  at  the  treatment.  Recently,
several  targets  including antioxidants,  anti-inflammatory  antiapoptotic,  neurotrophic  and antiamyloid/genesis  drugs
have been explored in the in vitro and in vivo models of AD. Naturally occurring dietary polyphenol compounds such as
curcumin,  resveratrol  and  green  tea  catechins  have  received  considerable  attention  as  attractive  candidates  for  AD
therapy.  These  polyphenolic  compounds  have  been  demonstrated  to  prevent  AD  due  to  their  antioxidant,  anti-
inflammatory, antiamyloidogenic effects and activating cellular stress adaptive to responses called “neurohormesis”
process [12]. The safety and efficacy of herbal medicines as either monotherapy or adjunct to conventional medicines
such  as  cholinesterase  inhibitors  and  nootropic  agents  for  AD  have  been  reviewed  based  on  data  from  sixteen
randomised clinical trials [13]. Fifteen out of the 16 trials provided evidence for the efficacy of herbal medicines in the
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treatment of AD. Ginkgo biloba extract Egb761 has been the most frequently studied. Huperzine A, a cholinesterase
inhibitor from Huperzia serrata has also been demonstrated to be effective against AD. Based on the systemic review of
clinical studies, herbal medicines are believed to be effective and safe medicines for AD treatment.
In this view finding for new compounds effective enough to act on various biochemical targets having new action
and low toxicity are requirements hard to meet for both scientists and the pharmaceutical industry. On the other hand,
the need to find remedies for this crippling disease has resulted in the reviving interest in natural chemistry. Active
constituents of plants, long-known herbs and their extracts may lead to the discovery of medicines successfully used for
the  treatment  of  AD.  It  is  generally  believed  that  research  on  natural  product  chemistry  has  a  large  number  of
unexploited values capable of providing new possibilities in the treatment of AD.
In  this  paper,  we  treat  mechanisms  that  might  underlie  the  improvements  in  cognitive  abilities,  neurovascular
functions and protection of nerve cells.
3. RESULTS AND DISCUSSION
The complete scientific name of the medicinal plants, the possible mechanism(s) of action and relevant references
can be found in Table (1). A number of medicinal plants, used in Chinese, Ayurvedic, Tibetan, Oriental and Kampo
medicines have a reputation enhancing cognitive functions.
Table 1. Medicinal plants exhibiting protection from Alzheimer’s disease.
No. Medicinal Plants, Name and (Family) Mechanism of Action References
1.
Abies koreana E.H. Wilson
(Pinaceae)




Exerts AChE inhibitory and antioxidant activity.





Exerts AChE inhibitory activity in vitro [26]
4.
Bacopa monnieri (L.) Pennel
(Plantaginaceae)
Improved cognitive function and reduced loss of neurons in animal model of AD.






Exerts AChE inhibitory activity in vitro. [33]
6.
Cassia obtusifolia (L.), Syn.: Senna
obtusifolia (L.) H.S. Irwin & Barneby
(Fabaceae)






Exerts AChE inhibitory activity





It sharpens memory and improves concentration as well as cognitive function. [32]
9.
Centella asiatica (L.), Urb.
(Apiaceae)
Reduces apoptosis and hippocampal Aβ levels in vitro and in vivo. Enhances
learning and memory function in mice models of AD. Potential use in the
prevention and treatment of beta-amyloid toxicity and AD.




Inhibits the formation of Aβ oligomers.
Reduces Aβ toxicity in neuronal PC12 cells.
Reduces Aβ oligomer and improves cognition in mice model of AD.
[49]




Reduces deposition of Aβ in cerebral cortex and tau-1 expression in
hippocampus.
Protect from amyloidosis and taupathy (neurofibrillary targets in brain of
ovarictomized rats.
Estrogenic activity.




Called horsebalm. Major constituents are carvacol and thymol that crosses blood-









Statistics indicate definitely (4.4-fold) lower incidence of AD in countries where
Curcuma longa is part of daily diet.
[32]
16. Danggui-Shaoyao-San (Apiaceae)
Improve cognitive function in age related memory dusfunction, reduces Aβ25-35
induced neuronal cell death and antiapoptotic effect in PC12 cells, ameliorate
Aβ25-35 induced impairment of spatial learning and memory in mice
[56, 57, 58, 59]
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Elicits AChE inhibitory activity. Improves learning and memory in scopolamine










Attenuates Aβ induced synaptotoxicity by preserving synaptophysin and inhibits










(Thunb. ex Murray) Trevis (Huperziaceae)





Reduces aggression and improves neuropsychiatric behavior in a cross over
randomized trial for treating agitated behaviors of demented people in Hong
Kong.




Protects against the toxicity of fibrillar Aβ1-42 and Aβ25-35 in rat cortical neurons





Improves learning and memory in and process organized synaptic signaling in
open label trial
Exerts antioxidant activity in mice model of AD
[73, 74]
25.
Morus alba L. syn.: Morus atropurpurea
Roxb. (Moraceae)
Augments the antioxidant defense system
















Inhibits β-secretase activity and decreases Aβ production [79, 80]
29.
Phangnalon saxatile (L.) Cass.
(Asteraceae)
Exhibits antioxidant and acetyl cholinesterase inhibitory activity. [81, 82]
30.
Physostigma venenosa (L.) Balf.
(Labiatae)




Pinus nigra J.F. Arnold, Syn.: Pinus
heldreichii H. Christ
(Pinaceae)
Exerts AChE inhibitory activity in vitro [84]
32.
Prosopis Africana
(Guill. & Perr) Taub.
(Fabaceae)








Reduces accumulation of Aβ42 and amyloid deposition in hippocampus in
transgenic mice (APP (SW)/Tg2576) and protected PC12 cells from H2O2
induced oxidative stress and increases cognitive function, and inhibits cell death





Exerts AChE inhibitory activity





Exerts AChE inhibitory activity
[35 - 40, 41, 42 -
45]
37.
Rehmannia glutinosa (Gaertn) Steud,
(Orbanchanceae)
Induces the expression of glial cell line derived neurotropic factor (GDNF) in
cells and cultured astrocytes




(Hybrid of Rhizophora apiculata & R.
Stylosa
(Rhizophoraceae)








Protects PC12 cells from neurotoxicity and tau protein hyperphosphorylation.
Improves learning and memory in patients of moderate AD in a double blind
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Exerts AChE inhibitory activity in vitro [26]
43.
Suaeda monica Forsk. Ex J.F. Gmel.
(Chenopodiaceae)
Exerts AChE inhibitory activity in vitro [26]
44.
Tabernaemontana divaricata(L) R.Br. ex
Roem. & Schult.
(Apocynaeeae)
Inhibits cortical AChE activity and enhances cortical neuronal activity [109]
45. Thespesia populnea (L) (Malvaceae)
Exerts inhibition of AChE activity. Improves learning and memory in diazepam













Valeriana amurensis P. Smirn.
(Valerianaceae)
Inhibits the expression of β-APP, Aβ1-40 and formation of senile plaques
decreases.
Reduces pro-inflammatory cytokines and cellular fate of cortical and






Inhibits neuronal apoptosis and exhibit antioxidant activity in cultures of rat
cortical neurons. Improves learning and memory in mice models of AD
[120]
50.
Withania somnifera (L) Dunal
(Solanaceae)
Semipurified extract of Withania somnifera reverses Alzheimer's disease
pathology. Nerving tonic, aphrodistic, rejuvenative, antioxidant activity, calming
effect, reverses behavioural deficit.




Exerts Aβ aggregating, antioxidant and AChE inhibitory activity. [127, 128]
Pharmacological investigations of plant-based anti- Alzheimer’s agents have led to the successful introduction of
galantamine into the clinical use; clinical trials with or huperzine A are going on.
The degeneration of acetylcholine (ACh) neurotransmission in the central nervous system due to neural degradation
is considered to be a major neuropathological characteristic of AD [14]. The animal models of AD are based on the use
of scopolamine (SCOP) to block muscarinic ACh receptors, which results in cognitive impairment [15, 16]. The SCOP
model is widely used to assess the activity of antidementia agents. At the same time, other neurotoxins, e.g. an inhibitor
of RNA-protein translation (cycloheximide), a serotonin neurotoxin (para-chloro-amphetamine), the amyloid β-peptide,
the ethanol, the aluminum applied on animal models of AD have also proved used to impair cognitive functions. The
cognitive  or  antidementia  effects  of  herbal  agents  on  behavioral  pharmacological  models,  as  soon  as  the  passive
avoidance  test,  the  Morris  water  maze  test,  the  T-maze,  and  both  the  radial  maze  paradigms  were  also  checked.
Although the mechanisms responsible for the cognition-enhancing effects of most herbal extracts and phytoconstituents
are still not completely understood. One or more of the following factors are involved in the improvement of central
ACh function; Inhibition of acetylcholinesterase (AChE) and facilitation of ACh synthesis or facilitation of the ACh
receptor function; prevention of β-amyloidogenesis by antioxidant action; protection against neurotoxicity and death of
nerve cells; facilitation of some neurotrophic effects, e.g., nerve growth factor (NGF). In the field of drug discovery,
more attention has been focused on neuroprotection in AD utilizing traditional medicinal plants. Natural compounds
with anti- oxidant, anti-inflammatory, anti-apoptotic, and neurofunctional regulational effects may exhibit preventive or
therapeutic features against AD. Herbal drugs of traditional medicine which have been well characterized and studied
for their behavioral effects and pharmacological properties, may be attractive candidates for further approved for the
treatment of patients with Alzheimer's disease, many herbal agents appeared to inhibit of AChE activity.
Tacrine was discriminated in 2013 because of concerns of hepatotoxicity. At the same time, substantial number of
herbal  extracts  and  isolated  constituents  have  antioxidant  and  neuroprotective  effects.  Antidementia  effects  are
evidenced  from  in  vitro  results  when  protection  from  nerve  cell  death  was  induced  by  exposure  to  abundant  free
radicals, excitatory toxins, toxic derivatives of amyloid precursor protein, and other neurotoxins.
CONCLUSION
Here  we  reiterate  the  fact  that  natural  products  represent  sources  of  compounds  having  potential  therapeutic
implication in AD and other cognitive dysfunctions.
Discovery of drugs from medicinal plants has traditionally been a long process and more cumbersome than other
(Table 1) contd.....
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ways of development.
Bioassay  screening  of  extract  libraries  faces  significant  difficulties  and  finding  of  lead  compound libraries  is  a
crucial strategy for discovering drugs. Revealing the precise pathogenesis of AD will give a wider insight into new drug
discovery and development and will rationalize drug design with better outcomes and therapeutic benefits. Considering
the multitarget, multicomponent action strategy of natural products widely used in the traditional medicine in AD, they
offer  an  unexploited  source  of  new  and  effective  therapy.  The  traditionally  applied  herbal  preparations  offer  an
adjunctive therapy to drugs acting on amyloidogenesis, AChE and cell death are intensively tested in order to offer
better  therapeutic  prospects  in  the  improvement  of  learning  and  memory  functions  of  patients  suffering  from AD.
Currently, very few plant-based medicines are accepted for clinical application. The reasons behind these very few
approvals  seem  to  be  the  complex  nature  of  the  chemical  components  in  herbal  preparations,  difficulties  in
standardization. Identification of the active ingradient(s) of medical herbs would significantly increase acceptance of
these  medicinal  plants  in  the  clinical  practice.  The  information  provided  in  the  present  review  on  numerous  plant
extracts, formulations and phytoconstituents that have preventive and therapeutic effects on AD in animal models can
be used to find new drug therapies for AD and related sequels.
In view of detrimental actions of the agents for AD, in particular treatment refractoriness, high recurrence and side
effects that occur in the course of long-term treatments, herbal drugs may offer an alternative possibility. In fact, some
human studies have confirmed the beneficial effects of herbal medicines in the prevention and treatment of dementia
[17 - 21]. Based on the encouraging results from animal studies and time-tested safety of some of the herbal agents, the
use of these agents as an adjunctive therapy along with conventional drugs can be suggested.
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